Under the terms of the agreement, SkinMedica has licensed exclusive rights to develop and market products based on the NYU technology, with a range of applications in the modulation of skin pigmentation.
Deal Type Partnership Sub-Category Licensing Agreement Deal Status Announced: 2009-10-26
Deal Participants
Partner 1 (Company) SkinMedica, Inc. Partner 2 (Company) New York University

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index